WASHINGTON - The U.S. drug regulator said Thursday it will allow the coronavirus vaccine developed by Pfizer Inc. to be transported and stored for up to two weeks at conventional freezer temperatures instead of the ultracold conditions previously required.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
